AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Chemomab Therapeutics Ltd. American Depositary Share
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00N0PMH92
1.03▼ 0.05 (-4.63%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
1.08
Day's Range
1.01 – 1.21
52-Week Range
1.01 – 3.44
Volume
25.0K
Avg Volume
105.7K
Share Statistics
Shares Outstanding
Employees
12
Exchange
XNAS
Listed
2021-03-17
Share count as of June 30, 2026

Chemomab Therapeutics Ltd. American Depositary Share (CMMB) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Chemomab Therapeutics Ltd. American Depositary Share (CMMB)
What is Chemomab Therapeutics Ltd. American Depositary Share's Market Cap?
Chemomab Therapeutics Ltd. American Depositary Share's Market Cap is $597.0M, based on as-reported figures from SEC (XBRL) filings.
What is Chemomab Therapeutics Ltd. American Depositary Share's Enterprise Value?
Chemomab Therapeutics Ltd. American Depositary Share's Enterprise Value is $591.0M, based on as-reported figures from SEC (XBRL) filings.
What is Chemomab Therapeutics Ltd. American Depositary Share's EV / EBITDA?
Chemomab Therapeutics Ltd. American Depositary Share's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Chemomab Therapeutics Ltd. American Depositary Share's Net Income (TTM)?
Chemomab Therapeutics Ltd. American Depositary Share's Net Income (TTM) is -$7.6M, based on as-reported figures from SEC (XBRL) filings.
What is Chemomab Therapeutics Ltd. American Depositary Share's EBITDA?
Chemomab Therapeutics Ltd. American Depositary Share's EBITDA is -$335.9M, based on as-reported figures from SEC (XBRL) filings.
What is Chemomab Therapeutics Ltd. American Depositary Share's Diluted EPS (TTM)?
Chemomab Therapeutics Ltd. American Depositary Share's Diluted EPS (TTM) is -0.01, based on as-reported figures from SEC (XBRL) filings.
What is Chemomab Therapeutics Ltd. American Depositary Share's Net Debt?
Chemomab Therapeutics Ltd. American Depositary Share's Net Debt is -$6.0M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · CMMBAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Jun 30, 2025Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Operating expenses
Research and Development Expense
General and administrative
Total operating expenses
Financing income, net
Loss before taxes
Taxes on income
Net loss for the period
Basic loss per Ordinary Share
Diluted loss per Ordinary Share